145 related articles for article (PubMed ID: 31306105)
1. Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Wu Y; Zhao J; Dong S; Wang Y; Li A; Jiang Y; Chen Z; Li C; Wang W; Zhang Z
Cancer Biomark; 2019; 25(4):341-350. PubMed ID: 31306105
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.
Liang WS; Aldrich J; Nasser S; Kurdoglu A; Phillips L; Reiman R; McDonald J; Izatt T; Christoforides A; Baker A; Craig C; Egan JB; Chase DM; Farley JH; Bryce AH; Stewart AK; Borad MJ; Carpten JD; Craig DW; Monk BJ
Int J Gynecol Cancer; 2014 Feb; 24(2):329-38. PubMed ID: 24418928
[TBL] [Abstract][Full Text] [Related]
3. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
[TBL] [Abstract][Full Text] [Related]
4. RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function.
Klymenko T; Gu Q; Herbert I; Stevenson A; Iliev V; Watkins G; Pollock C; Bhatia R; Cuschieri K; Herzyk P; Gatherer D; Graham SV
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021401
[TBL] [Abstract][Full Text] [Related]
5. Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer.
Wang C; Bai R; Liu Y; Wang K; Wang Y; Yang J; Cai H; Yang P
Med Oncol; 2023 Jan; 40(2):78. PubMed ID: 36635412
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of HPV-independent cervical cancers.
Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing in cervical adenocarcinoma in mainland Chinese patients.
Zhang X; Guo J; Cai Y; Sheng X
Transl Cancer Res; 2020 Nov; 9(11):6889-6899. PubMed ID: 35117297
[TBL] [Abstract][Full Text] [Related]
8. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
Huang J; Qian Z; Gong Y; Wang Y; Guan Y; Han Y; Yi X; Huang W; Ji L; Xu J; Su M; Yuan Q; Cui S; Zhang J; Bao C; Liu W; Chen X; Zhang M; Gao X; Wu R; Zhang Y; Xu H; Zhu S; Zhu H; Yang L; Xu X; Zhou P; Liang Z
J Med Genet; 2019 Mar; 56(3):186-194. PubMed ID: 30567904
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization of cervical cancer based on human papillomavirus status.
Zhang L; Jiang Y; Lu X; Zhao H; Chen C; Wang Y; Hu W; Zhu Y; Yan H; Yan F
Gynecol Oncol; 2019 Mar; 152(3):629-637. PubMed ID: 30581036
[TBL] [Abstract][Full Text] [Related]
13. Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.
Rosa MN; Evangelista AF; Leal LF; De Oliveira CM; Silva VAO; Munari CC; Munari FF; Matsushita GM; Dos Reis R; Andrade CE; Souza CP; Reis RM
Sci Rep; 2019 Feb; 9(1):1913. PubMed ID: 30760827
[TBL] [Abstract][Full Text] [Related]
14. Invasive cervical tumors with high and low HPV titer represent molecular subgroups with different disease etiology.
Cui T; Enroth S; Ameur A; Gustavsson I; Lindquist D; Gyllensten U
Carcinogenesis; 2019 Apr; 40(2):269-278. PubMed ID: 30596972
[TBL] [Abstract][Full Text] [Related]
15. Landscape of genomic alterations in cervical carcinomas.
Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of HPV physical status and integration sites in cervical cancer.
Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T
Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
[TBL] [Abstract][Full Text] [Related]
18. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
Kusakabe M; Taguchi A; Tanikawa M; Hoshi D; Tsuchimochi S; Qian X; Toyohara Y; Kawata A; Wagatsuma R; Yamaguchi K; Yamamoto Y; Ikemura M; Sone K; Mori-Uchino M; Matsunaga H; Tsuruga T; Nagamatsu T; Kukimoto I; Wada-Hiraike O; Kawazu M; Ushiku T; Takeyama H; Oda K; Kawana K; Hippo Y; Osuga Y
Cancer Med; 2023 Apr; 12(7):8476-8489. PubMed ID: 36691316
[TBL] [Abstract][Full Text] [Related]
19. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
Yang C; Xu W; Gong J; Liu Z; Cui D
Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
[TBL] [Abstract][Full Text] [Related]
20. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
